首页> 外文期刊>European journal of human genetics: EJHG >Mucolipidosis type IV: the origin of the disease in the Ashkenazi Jewish population.
【24h】

Mucolipidosis type IV: the origin of the disease in the Ashkenazi Jewish population.

机译:IV型粘膜脂溢性疾病:该病起源于Ashkenazi犹太人口。

获取原文
获取原文并翻译 | 示例
           

摘要

Mucolipidosis type IV (MLIV) is a neurodegenerative lysosomal storage disease in which most of the patients diagnosed hitherto are Ashkenazi Jews. The basic metabolic defect causing this disease is still unknown and the relevant gene has not yet been mapped or cloned. Seventeen Israel Ashkenazi families with MLIV patients had been interviewed to study their family origin. Although the families immigrated to Israel from various European countries they all could trace their roots three to four generations back to northern Poland or the immediate neighbouring country, Lithuania. Furthermore, there are only one or two ultraorthodox families among the 70-80 Ashkenazi families with MLIV patients worldwide, a marked under-representation of this group which constitutes at least 10% of the Ashkenazi population. This data indicate that MLIV mutation occurred only around the 18th and 19th centuries, after the major expansion of this population, in a founder in this defined European region belonging to a more modern, secular family.
机译:IV型粘膜脂溢性病(MLIV)是一种神经退行性溶酶体贮积病,迄今诊断出的大多数患者都是Ashkenazi犹太人。导致该疾病的基本代谢缺陷仍是未知的,相关基因尚未作图或克隆。采访了17个以色列MLIV患者的Ashkenazi家庭,以研究其家庭出身。尽管这些家庭从欧洲各个国家移民到以色列,但他们都有三到四代的历史可以追溯到波兰北部或附近的立陶宛。此外,在全世界有MLIV患者的70-80个阿什肯纳齐家庭中,只有一个或两个超正统家庭,该群体的代表性不足,该群体至少占阿什肯纳兹人口的10%。该数据表明,MLIV突变仅在该人群大量扩展后的18和19世纪左右才发生,在该定义的欧洲地区的一个创始人中,该创始人属于一个更现代的世俗家庭。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号